Search Results - N Epperla

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY PRIMARY REFRACTORY STATUS by K Saverno, KMZ Savill, B Feinberg, J Galvin, P Pathak, T Amoloja, N Epperla, LJ Nastoupil

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


  2. 2

    REAL-WORLD SEQUENTIAL USE OF CD19-DIRECTED THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: TAFASITAMAB PRECEDING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY by N Epperla, LJ Nastoupil, B Feinberg, J Galvin, P Pathak, T Amoloja, D Gentile, K Saverno

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


  3. 3

    REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY AGE GROUP (> 70 YEARS AND 70 YEARS) by N Epperla, LJ Nastoupil, KMZ Savill, B Feinberg, J Galvin, P Pathak, T Amoloja, M Vukcevic, K Saverno

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


Search Tools: